M2eA universal influenza vaccine (Molecular Express)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameM2eA universal influenza vaccine (Molecular Express)

Drug Alias Nameliposome-based influenza vaccine containing matrix 2 ectodomain A segments (Molecular Express)influenza vaccine (Molecular Express)

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionMatrix protein 2 modulators

TargetsMatrix protein 2

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMolecular Express Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMolecular Express Inc

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A